Ghrelin Suppression by Octreotide in Prader-Willi

NCT01613495 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

2

Enrollment

OTHER

Sponsor class

Conditions

Prader Willis Syndrome

Interventions

DRUG: Placebo
DRUG: Octreotide

Sponsor

Oregon Health and Science University